Please use this identifier to cite or link to this item:
|Title:||The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission.||Austin Authors:||Burisch, Johan;Zhao, Mirabella;Odes, Selwyn;De Cruz, Peter P ;Vermeire, Severine;Bernstein, Charles N;Kaplan, Gilaad G;Duricova, Dana;Greenberg, Dan;Melberg, Hans O;Watanabe, Mamoru;Ahn, Hyeong Sik;Targownik, Laura;Pittet, Valérie E H;Annese, Vito;Park, K T;Katsanos, Konstantinos H;Høivik, Marte L;Krznaric, Zeljko;Chaparro, María;Loftus, Edward V;Lakatos, Peter L;Gisbert, Javier P;Bemelman, Willem;Moum, Bjorn;Gearry, Richard B;Kappelman, Michael D;Hart, Ailsa;Pierik, Marieke J;Andrews, Jane M;Ng, Siew C;D'Inca, Renata;Munkholm, Pia||Affiliation:||Gastro Unit, Medical Division, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Gastroenterology and Hepatology
Department of Gastroenterology and Hepatology, University Hospital Leuven, Leuven, Belgium; Faculty of Medicine, KU Leuven University, Leuven, Belgium.
IBD Clinical and Research Centre, University of Manitoba, Winnipeg, MB, Canada; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Department of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada.
IBD Clinical and Research Centre for IBD, ISCARE, Prague, Czech Republic; Department of Pharmacology, Faculty of Medicine, Charles University, Prague, Czech Republic.
Department of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Guilford Glazer Faculty of Business and Management, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Department of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.
Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Preventive Medicine, College of Medicine, Korea University, Seoul, South Korea.
Division of Gastroenterology and Hepatology, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Department of Epidemiology and Health Systems, Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.
Division of Gastroenterology, Department of Internal Medicine, Fakeeh University Hospital, Dubai, United Arab Emirates.
Stanford Health Care, Packard Health Alliance, Alameda, CA, USA; Genentech (Roche Group), South San Francisco, CA, USA.
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Ioannina School of Health Sciences, Ioannina, Greece.
Department of Gastroenterology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Gastroenterology, Hepatology and Nutrition, University Hospital Zagreb, Zagreb, Croatia.
Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Universidad Autónoma de Madrid, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Division of Gastroenterology, McGill University Montreal, QC, Canada; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
Department of Surgery, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Medicine, University of Otago, Christchurch, New Zealand.
Division of Pediatric Gastroenterology, Department of Pediatrics and Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
IBD Unit, St Mark's Hospital, Middlesex, UK.
Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, Netherlands.
IBD Service, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, SA, Australia; Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia.
Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.
Department of Gastroenterology, Copenhagen University Hospital-North Zealand, Hillerød, Denmark.
Medicine (University of Melbourne)
|Issue Date:||2-Mar-2023||metadata.dc.date:||2023||Publication information:||The Lancet. Gastroenterology & Hepatology 2023||Abstract:||The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease and ulcerative colitis in both developed and newly industrialised countries, but also the chronic nature of the diseases, the need for long-term, often expensive treatments, the use of more intensive disease monitoring strategies, and the effect of the diseases on economic productivity. This Commission draws together a wide range of expertise to discuss the current costs of IBD care, the drivers of increasing costs, and how to deliver affordable care for IBD in the future. The key conclusions are that (1) increases in health-care costs must be evaluated against improved disease management and reductions in indirect costs, and (2) that overarching systems for data interoperability, registries, and big data approaches must be established for continuous assessment of effectiveness, costs, and the cost-effectiveness of care. International collaborations should be sought out to evaluate novel models of care (eg, value-based health care, including integrated health care, and participatory health-care models), as well as to improve the education and training of clinicians, patients, and policy makers.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/32254||DOI:||10.1016/S2468-1253(23)00003-1||ORCID:||Journal:||The Lancet. Gastroenterology & Hepatology||PubMed URL:||36871566||ISSN:||2468-1253||Type:||Journal Article||Subjects:||inflammatory bowel disease|
|Appears in Collections:||Journal articles|
Show full item record
checked on Mar 30, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.